Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Accumulated Expenses (2020 - 2024)

Pulse Biosciences (PLSE) has 6 years of Accumulated Expenses data on record, last reported at $2.0 million in Q4 2025.

  • For Q4 2025, Accumulated Expenses rose 183.52% year-over-year to $2.0 million; the TTM value through Dec 2025 reached $2.0 million, up 183.52%, while the annual FY2025 figure was $2.0 million, 183.52% up from the prior year.
  • Accumulated Expenses reached $2.0 million in Q4 2025 per PLSE's latest filing, down from $4.0 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $5.6 million in Q1 2021 and bottomed at $27000.0 in Q3 2021.
  • Average Accumulated Expenses over 5 years is $2.2 million, with a median of $2.0 million recorded in 2025.
  • Peak YoY movement for Accumulated Expenses: tumbled 98.81% in 2021, then surged 3466.0% in 2024.
  • A 5-year view of Accumulated Expenses shows it stood at $3.8 million in 2021, then crashed by 31.96% to $2.6 million in 2022, then surged by 46.97% to $3.8 million in 2023, then plummeted by 81.7% to $698000.0 in 2024, then surged by 183.52% to $2.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Accumulated Expenses were $2.0 million in Q4 2025, $4.0 million in Q1 2025, and $698000.0 in Q4 2024.